Research Tracker›Biomarker Atlas›PACVS›Heart rate variability (HRV)

Heart rate variability (HRV) in PACVS

Heart rate variability (HRV), also described as Autonomic function, is a functional marker reported as reduced in PACVS (PACVS, PCVS) when patients are compared with healthy controls. Clinically, it has been associated with dysautonomia, POTS. This entry summarises Mundorf et al. 2024. Group-level associations like this do not translate into an individual diagnostic cut-off.

↓ ReducedFunctional

Summary

Direction in PACVS↓ Reduced — lower than in the comparison group
CategoryFunctional
Also described asAutonomic function
Compared againstHC (healthy controls)
Associated symptomsDysautonomia, POTS
Test typeClinical or physiological test
SourceMundorf et al. 2024 — doi:10.3390/vaccines12070790
Condition atlasPACVS Biomarker Atlas

Other conditions where Heart rate variability (HRV) is reported

See the cross-condition hub: Heart rate variability (HRV) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Autonomic Function (14 registered trials use a matching outcome measure).

Clinical trials using Heart rate variability (HRV) as an outcome

NCT07724834Not Yet Recruiting
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Outcome measure: Improvement in symptoms of autonomic dysfunction as measured by the Composite Autonomic Symptom Score (COMPASS-31)
NCT07317401Not Yet Recruiting
Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment
Outcome measure: Objective autonomic, neurophysiological, and functional performance measures
NCT05697640Active Not Recruiting
Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome
Outcome measure: Improvement in symptoms of autonomic dysfunction as measured by the Composite Autonomic Symptom Score (COMPASS-31)
NCT05710770Completed
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
Outcome measure: Improvement in symptoms of autonomic dysfunction as measured by the Composite Autonomic Symptom Score (COMPASS-31)
NCT07190105Completed
Vagal Approaches on Long COVID-19
Outcome measure: Body Perception Questionnaire (BPQ)
NCT07110714Recruiting
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Outcome measure: Autonomic function (heart rate variability by photoplethysmography)
NCT06968104Active Not Recruiting
Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS
Outcome measure: Autonomic Function
NCT05630040Completed
VNS for Long-COVID-19
Outcome measure: Composite Dysautonomia Symptom Score (COMPASS 31)

6 more trials reference this marker.

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Heart Rate Variability — specialty laboratory test. Functional autonomic measure; ordered via autonomic/POTS workup, not a single standard lab code.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Functional markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Heart rate variability (HRV) high or low in PACVS?

Reduced. Studies summarised in the OSMF atlas report lower Heart rate variability (HRV) in PACVS than in healthy controls. Source: Mundorf et al. 2024.

What symptoms is Heart rate variability (HRV) associated with in PACVS?

The cited literature associates this marker with Dysautonomia, POTS. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Heart rate variability (HRV)?

It is measured as a clinical or physiological test. Commercial laboratories such as NASA Lean Test / clinical autonomic workup list an orderable assay.

Is one abnormal Heart rate variability (HRV) result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Heart rate variability (HRV) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Heart rate variability (HRV) specific to PACVS?

No. The same marker is also reported in Gulf War Illness, Lyme Disease, ME/CFS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Heart rate variability (HRV) in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/heart-rate-variability-hrv.html

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.